What does the evidence say about Saffron Depression Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Saffron Depression Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - This narrative review critically evaluates clinical evidence on commonly used herbal preparations, with particular emphasis on herb-drug interactions, adverse effects, and issues related to product adulteration. [Căuș MN (2026); evidence level 3] - However, clinically relevant risks were identified, including cytochrome P450-mediated drug interactions, excessive sedation, serotonin syndrome, and toxic effects associated with adulterated products, such as hepatotoxicity, cardiovascular events, and neurological disturbances. [Căuș MN (2026); evidence level 3] - Increased awareness of herb-drug interactions and stricter quality control are essential to optimize therapeutic outcomes and minimize harm. [Căuș MN (2026); evidence level 3] - Background/Objectives: Plant-based supplements are widely used for the management of anxiety, depression, and insomnia. [Căuș MN (2026); evidence level 3] - In this review, we want to systematically sort out the evidence about the antidepressant effects of five main culinary spices: turmeric, saffron, ginger, chili pepper and black pepper. [Zhong Lu (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.